ArticleCardio-oncology (London, England)2021

Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data.

Maria Klara Frey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.